We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
CVS Health Corporation | NYSE:CVS | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.37 | 0.63% | 59.01 | 59.08 | 58.35 | 58.73 | 8,356,492 | 00:02:50 |
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person
*
Roberts Jonathan C |
2. Issuer Name
and
Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) EVP & Chief Operating Officer |
ONE CVS DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
WOONSOCKET, RI 02895- |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 4/2/2017 | F | 4655 (1) | D | $78.50 | 33812.1293 | D | |||
Common Stock (restricted) | 4/3/2017 | A | 25624 (2) | A | $78.05 | 70780 | D | |||
Common Stock (pep) | 11702.5082 | D | ||||||||
ESOP Common Stock | 5319.994 | I | By ESOP | |||||||
Stock Unit | 141331.4939 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option | $78.05 | 4/3/2017 | A | 200358 | 4/3/2018 (3) | 4/3/2024 | Common Stock | 200358 | $78.05 | 200358 | D | ||||
Phantom Stock Credits | $1.00 | (4) | (4) | Common Stock | 1418.9113 | 1418.9113 | D | ||||||||
Stock Option | $34.96 | 4/1/2012 (5) | 4/1/2018 | Common Stock | 85743 | 85743 | D | ||||||||
Stock Option | $45.07 | 4/2/2013 (6) | 4/2/2019 | Common Stock | 77639 | 77639 | D | ||||||||
Stock Option | $54.53 | 4/1/2014 (7) | 4/1/2020 | Common Stock | 68844 | 68844 | D | ||||||||
Stock Option | $74.29 | 4/1/2015 (8) | 4/1/2021 | Common Stock | 73433 | 73433 | D | ||||||||
Stock Option | $45.93 | 9/4/2015 (9) | 9/4/2022 | Common Stock | 108870 | 108870 | D | ||||||||
Stock Option | $102.26 | 4/1/2016 (10) | 4/1/2022 | Common Stock | 68482 | 68482 | D | ||||||||
Stock Option | $104.82 | 4/1/2017 (11) | 4/1/2023 | Common Stock | 161318 | 161318 | D |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Roberts Jonathan C
ONE CVS DRIVE WOONSOCKET, RI 02895- |
|
|
EVP & Chief Operating Officer |
|
Signatures
|
||
Jonathan C. Roberts | 4/4/2017 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year CVS Health Chart |
1 Month CVS Health Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions